Forever Labs, the parent company of SuperShot^® PRP, will utilize DataBiologics to track outcomes for their innovative PRP process that allows autologous extracellular vesicles to be isolated.

Physicians who already collect, review and analyze data related to their orthobiologic treatment outcomes via the DataBiologics platform, can now include SuperShot® PRP procedures in their data. This newly collected data can then be compared to outcomes for standard PRP procedures.